Nath Bio-Genes (India) Limited (NATHBIOGEN.BO)
INR 193.5
(0.21%)
INR 193.5
(0.21%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 614.8 Million | 383.66 Million | 170.47 Million | 11.12 Million | 94.79 Million | -229.35 Million |
| Net Income | 361.69 Million | 361.64 Million | -634.33 Million | 567.51 Million | 485.08 Million | 388.68 Million |
| Depreciation & Amortization | 32.61 Million | 30.12 Million | 30.84 Million | 28.15 Million | 14.52 Million | 14.46 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 196.26 Million | -98.13 Million | -189.27 Million | -651.27 Million | -445.01 Million | -636.39 Million |
| Other non-cash items | 130.82 Million | 90.03 Million | 963.24 Million | 66.73 Million | 40.19 Million | 3.89 Million |
| Investing Cash Flow | -277.26 Million | -28.84 Million | -198.51 Million | -102.82 Million | -144.37 Million | -204.83 Million |
| Investments in PPE | -83.92 Million | -25.48 Million | -11.16 Million | -115.98 Million | -162.03 Million | -222.95 Million |
| Acquisitions | 501 Thousand | 471 Thousand | 731 Thousand | 1.52 Million | 4.64 Million | 839.95 Thousand |
| Investment purchases | -9.98 Million | -2000.00 | -3000.00 | -502 Thousand | -2400.00 | -2400.00 |
| Sales/Maturities of investments | - | -496 Thousand | 10.79 Million | 11.61 Million | 119.65 Million | 17.28 Million |
| Other Investing Activities | -183.35 Million | -3.32 Million | -198.87 Million | 516 Thousand | -106.63 Million | -1.00 |
| Financing Cash Flow | -45.67 Million | -16.67 Million | -222.32 Million | 164 Million | 55.63 Million | 201.39 Million |
| Debt repayment | -7.66 Million | -122.53 Million | -78.2 Million | -252.2 Million | -121.09 Million | -253.44 Million |
| Dividends payments | -38 Million | -38 Million | -38 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1000.00 | 143.86 Million | -106.11 Million | 416.2 Million | 176.72 Million | 454.84 Million |
| Accounts receivables | 27.64 Million | -118.82 Million | 210.22 Million | -20.58 Million | 13.49 Million | -256.82 Million |
| Accounts payables | 155.6 Million | -150.46 Million | 199.92 Million | -229.72 Million | 180.04 Million | 136.02 Million |
| Inventory | -224.62 Million | 124.96 Million | 59.57 Million | -219.91 Million | -489.51 Million | -318.99 Million |
| Other working capital | 237.63 Million | 46.19 Million | -658.98 Million | -181.04 Million | -149.03 Million | -196.6 Million |
| Cash at beginning of period | 379.9 Million | 41.8 Million | 292.16 Million | 219.84 Million | 213.79 Million | 446.58 Million |
| Cash at end of period | 774.09 Million | 379.95 Million | 41.8 Million | 292.16 Million | 219.84 Million | 213.79 Million |
| Capital Expenditure | -83.92 Million | -25.48 Million | -11.16 Million | -115.98 Million | -162.03 Million | -222.95 Million |
| Effect of forex changes on cash | - | -1000.00 | - | -1000.00 | - | -2.00 |
| Net cash flow / Change in cash | 394.19 Million | 338.14 Million | -250.35 Million | 72.31 Million | 6.05 Million | -232.78 Million |
| Free Cash Flow | 530.87 Million | 358.17 Million | 159.31 Million | -104.85 Million | -67.24 Million | -452.31 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 361.69 Million | 13.19 Million | 20.33 Million | 331.8 Million | 361.64 Million | 14.36 Million |
| Depreciation & Amortization | 32.61 Million | 7.6 Million | 7.6 Million | 7.6 Million | 30.12 Million | 9.9 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 196.26 Million | - | - | - | -98.13 Million | - |
| Other non-cash items | 130.82 Million | -7.6 Million | -7.6 Million | -7.6 Million | 90.03 Million | -9.9 Million |
| Investing Cash Flow | -277.26 Million | - | - | - | -28.84 Million | - |
| Investments in PPE | -83.92 Million | - | - | - | -25.48 Million | - |
| Acquisitions | 501 Thousand | - | - | - | 471 Thousand | - |
| Investment purchases | -9.98 Million | - | - | - | -2000.00 | - |
| Sales/Maturities of investments | - | - | - | - | -496 Thousand | - |
| Other Investing Activities | -183.35 Million | - | - | - | -3.32 Million | - |
| Financing Cash Flow | -45.67 Million | - | - | - | -16.67 Million | - |
| Debt repayment | -7.66 Million | - | - | - | -122.53 Million | - |
| Dividends payments | -38 Million | - | - | - | -38 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1000.00 | - | - | - | 143.86 Million | - |
| Accounts receivables | 27.64 Million | - | - | - | -118.82 Million | - |
| Accounts payables | 155.6 Million | - | - | - | -150.46 Million | - |
| Inventory | -224.62 Million | - | - | - | 124.96 Million | - |
| Other working capital | 237.63 Million | - | - | - | 46.19 Million | - |
| Cash at beginning of period | 379.9 Million | 152.26 Million | 131.92 Million | 379.9 Million | 41.8 Million | 365.53 Million |
| Cash at end of period | 774.09 Million | 13.19 Million | 152.26 Million | 331.8 Million | 379.95 Million | 379.9 Million |
| Capital Expenditure | -83.92 Million | - | - | - | -25.48 Million | - |
| Effect of forex changes on cash | - | - | - | - | -1000.00 | - |
| Net cash flow / Change in cash | 394.19 Million | -139.06 Million | 20.33 Million | -48.09 Million | 338.14 Million | 14.36 Million |
| Free Cash Flow | 530.87 Million | 13.19 Million | 20.33 Million | 331.8 Million | 358.17 Million | 14.36 Million |
SYTIXSE
SAP
002709
WEGZY
GPGC
XGC